Hybrid Nanoparticle for Co-delivering Paclitaxel and Dihydroartemisinin to Exhibit Synergic Anticancer Therapeutics

CONCLUSION: Dual-drug-loaded hybrid PLGA-lecithin NP is a potential system to minimize severe side effects while enhancing antitumor efficacy, in which lyophilization is a key process to increase stability.</p>.PMID:38321897 | DOI:10.2174/0115680096283208231229103822

Source: Current Cancer Drug Targets - February 7, 2024 Category: Cancer & Oncology Authors: Bao Ngoc Tran Thu Thi Kim Ninh Thao Thi Do Phuong Thi Do Chien Ngoc Nguyen Source Type: research